The new Oxford classification of IgA nephropathy has been developed as a pathological classification system to reliably predict the risk of disease progression. Future studies need to demonstrate the value of this classification in directing individualized therapeutic decisions for patients with IgA nephropathy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Case report on pathogenetic link between gluten and IgA nephropathy
BMC Gastroenterology Open Access 16 May 2018
-
Efficacy of tonsillectomy for the treatment of immunoglobulin A nephropathy recurrence after kidney transplantation
Renal Replacement Therapy Open Access 06 March 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Roberts, I. S. et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76, 546–556 (2009).
Cattran, D. C. et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 76, 534–545 (2009).
Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65, 521–530 (2004).
Eitner, F., Ackermann, D., Hilgers, R. D. & Floege, J. Supportive versus immunosuppressive therapy of progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. J. Nephrol. 21, 284–289 (2008).
Suzuki, H. et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119, 1668–1677 (2009).
Gharavi, A. G. et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23. Nat. Genet. 26, 354–357 (2000).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Eitner, F., Floege, J. The Oxford classification—predicting progression of IgAN. Nat Rev Nephrol 5, 557–559 (2009). https://doi.org/10.1038/nrneph.2009.150
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2009.150
This article is cited by
-
Case report on pathogenetic link between gluten and IgA nephropathy
BMC Gastroenterology (2018)
-
Efficacy of tonsillectomy for the treatment of immunoglobulin A nephropathy recurrence after kidney transplantation
Renal Replacement Therapy (2017)
-
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
Kidney International (2012)
-
Pathologieklassifikation der Immunglobulin-A-Nephropathie
Der Nephrologe (2011)